Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games (“Virtual Therapeutics”), announces that it has successfully completed the tender offer commenced on June 3, 2024, to acquire all outstanding shares of common stock of Akili, Inc. (Nasdaq: AKLI) (“Akili”) for $0.4340 per share (the “Offer Price”). “The completion of this acquisition provides a foundation for us to build a leading digital health company that is capable of bringing new behavioral services to as many patients as possible,” said Dan Elenbaas, co-founder and CEO of Virtual Therapeutics.”
Read the full article: Virtual Therapeutics Completes Acquisition of Akili Interactive //
Source: https://www.businesswire.com/news/home/20240701029834/en/Virtual-Therapeutics-Announces-Results-of-Tender-Offer-to-Acquire-Akili-Interactive